Vaping and Anxiety
Nicotine feels like it calms you down. The evidence says it makes anxiety worse over time.
One of the most common reasons people give for continuing to vape is that it helps with their anxiety. This is understandable and, from the inside, it feels true. The hit arrives, the tension drops, the breathing settles. It looks like a tool for managing stress, and in the moment, it works exactly like one.
The evidence says something more complicated, and less comfortable.
The withdrawal illusion
Nicotine withdrawal includes a specific set of symptoms: irritability, restlessness, difficulty concentrating and increased anxiety [4]. These symptoms begin within hours of the last dose and peak within the first few days. They feel exactly like general anxiety because the mechanism overlaps: the same receptor systems, the same subjective experience.
When a dependent user takes a hit, these symptoms resolve rapidly. The relief is real. But the condition being relieved was created by the nicotine itself. The cycle works like this: nicotine wears off, withdrawal-driven anxiety rises, the next hit resolves it, the user learns that vaping “helps” with anxiety. The device is solving a problem it created, and it does so reliably enough that the illusion is maintained for as long as the user keeps vaping [5].
This is not a moral judgment. It is a pharmacological description of how nicotine dependence interacts with subjective anxiety.
The cycle is particularly convincing because the relief is immediate. Nicotine reaches the brain within seconds of inhalation. That speed makes the association between the hit and the relief incredibly strong, stronger than any actual anxiety treatment could produce. A medication that takes two weeks to work does not create the same reinforcing loop. The speed of the relief is what makes the illusion so persistent.
How the cycle escalates
The withdrawal-relief loop does not stay stable. Over time, tolerance develops: the same dose of nicotine produces less relief, while the withdrawal between doses becomes more noticeable. The practical result is that a vaper who started with occasional use as a social habit ends up using more frequently, at higher nicotine concentrations, with shorter intervals between hits. Each step up feels like managing the same problem; in reality, each step is deepening the dependence that creates the problem.
Pod devices accelerated this pattern. The nicotine salt formulations used in most pods allow higher concentrations without the throat harshness that older freebase nicotine produced. A 5% pod delivers roughly 50 mg/mL of nicotine per hit, and the smooth delivery means the dose can increase without much sensory feedback. The device is designed for comfort at levels that build dependence quickly, and the anxiety-relief perception is part of what makes high-frequency use feel reasonable rather than concerning.
The sleep connection
There is a second pathway by which nicotine worsens anxiety, and it runs through sleep. Nicotine disrupts sleep architecture: it reduces slow-wave deep sleep and causes micro-awakenings as blood nicotine drops overnight [4]. The result is chronic sleep deprivation that most users do not attribute to the device because it accumulates gradually. One bad night is noticeable. A slow decline in sleep quality over months is not; it becomes the new baseline.
Poor sleep and anxiety are bidirectional: anxiety makes it harder to sleep, and poor sleep makes anxiety worse. Nicotine inserts itself into both sides of that loop. It raises baseline anxiety through the withdrawal cycle, and it degrades the sleep that would otherwise help regulate that anxiety. The net effect is that a vaper’s nervous system is operating on less rest and more stimulation than it would be without the device, and both of those factors converge on the same subjective experience: feeling anxious, on edge, and unable to settle.
This matters practically because it changes what to expect during the first week of quitting. Sleep often gets worse before it gets better, typically during the first three to five days, as the brain adjusts to the absence of nicotine. This temporary worsening can amplify the withdrawal anxiety and make it feel like quitting is making everything worse. It is making sleep temporarily worse; the anxiety is responding to the sleep disruption compounding the withdrawal. Knowing this in advance does not make the first week easy, but it reframes the experience as a predictable phase rather than evidence that quitting was a mistake.
After the first week, sleep begins to improve. By the end of the first month, most former vapers report sleeping better than they did while vaping. This is one reason why anxiety after quitting often improves more than expected. People who quit are not just breaking the withdrawal-relief cycle. They are also recovering sleep quality, and the compounding effect of those two improvements produces a reduction in baseline anxiety that exceeds what either change would accomplish alone.
What the population data shows
A cross-sectional analysis of over 886,000 adults in the Behavioral Risk Factor Surveillance System found that e-cigarette use was significantly associated with a history of depression and current anxiety [3]. Cross-sectional data cannot prove causation (anxious people may be more likely to start vaping), but it is consistent with other evidence pointing in the same direction.
Longitudinal studies in adolescents and young adults show that initiating e-cigarette use is associated with subsequent increases in depressive and anxiety symptoms, even after controlling for baseline mental health [2]. The direction of effect is consistent with nicotine creating or maintaining anxiety rather than treating it.
The combined picture from multiple study designs, cross-sectional, longitudinal, and the meta-analyses on smoking cessation, points in the same direction: regular nicotine use is associated with worse anxiety outcomes, not better ones, and quitting is associated with improvement.
The dose matters more than people realize
The relationship between nicotine dose and anxiety is not flat. Higher-concentration pods (5% or 50 mg/mL) produce a sharper blood-nicotine spike, which means the subsequent drop is also steeper. A steeper drop means withdrawal symptoms, including anxiety, onset faster and feel more acute. The user of a high-concentration pod may feel the first edge of withdrawal-driven anxiety within 20 to 30 minutes of their last hit, compared to an hour or more for someone using a lower-concentration device.
This means that the anxiety-relief cycle is tighter and more reinforcing with higher-nicotine products. The device trains the user faster: the faster the anxiety arrives, the faster the hit resolves it, the stronger the association becomes. It is not coincidental that the generation of vapers who report the most difficulty quitting is also the generation that started on high-nicotine salt devices. The pharmacology predicts it.
Switching to a lower-nicotine device or liquid, while not a quit method on its own, can loosen this cycle. When the blood-nicotine drop is more gradual, the withdrawal-driven anxiety is less sharp, less urgent, and less likely to feel like a crisis. This is one reason some tapering approaches have appeal, even though the evidence for tapering as a standalone quit strategy is limited. The appeal is real even when the evidence base is thin: a slower cycle feels more manageable, and feeling manageable matters when anxiety is the primary barrier.
What happens when you quit
The strongest evidence comes from smoking cessation research, which has a much larger evidence base. A 2021 meta-analysis of 102 studies, covering over 169,000 participants, found that quitting smoking was associated with significant reductions in anxiety, depression and stress [1]. The improvements in anxiety were comparable in magnitude to the effects of antidepressant treatment.
That last point is worth sitting with. Quitting nicotine improved anxiety to a degree comparable to starting an antidepressant. This does not mean nicotine cessation replaces treatment for diagnosed anxiety disorders. It means that for many users, the apparent anxiety they are managing with the device is substantially driven by the device itself, and quitting resolves it.
The initial weeks of quitting involve a temporary increase in anxiety as withdrawal peaks. This is the period when the illusion is hardest to shake, because the anxiety is real and a single hit would relieve it. The withdrawal anxiety follows a known timeline: it peaks in the first week, improves substantially by weeks two and three, and for most people has returned to or dropped below pre-quitting levels by week four [4].
The improvement continues past the first month. Many former vapers report that their baseline anxiety at three months is lower than it was at any point during their vaping. This makes pharmacological sense: the constant cycle of withdrawal and relief creates a chronically elevated stress response, and removing that cycle allows the system to stabilize at a lower level.
The trigger replacement problem
For vapers who use the device specifically to manage stress or anxiety, quitting requires replacing the device with something that actually works. This is not a trivial step, and it is often underemphasized in quit plans. The hit was a four-second stress management tool, instantly available. Replacing it with “take a deep breath” is technically accurate advice but practically insufficient in the moment.
More useful: identify the two or three highest-frequency anxiety triggers and develop a specific alternative for each. A walk, a cold glass of water, a brief change of physical location, a deliberate breathing exercise that takes 60 seconds. The alternative does not need to be as fast as the hit; it needs to be specific and available when the craving arrives. Vague plans fail because cravings are specific, and they require a response that is equally specific.
The practical difference between someone who quits and manages the anxiety transition well and someone who relapses in week two is often not motivation or willpower. It is preparation. The person who has a specific plan for the 3 PM stress craving handles it differently than the person who planned to “be strong.” Both wanted to quit. One had a response ready.
NRT plays a specific role here. The patch provides a baseline of nicotine that prevents the worst of withdrawal-driven anxiety without the reinforcing speed of the hit. The gum or lozenge provides a controllable dose for acute anxiety moments. Neither replaces the behavioral habit of reaching for the device, but they take the pharmacological edge off the anxiety long enough for the behavioral replacement to work. For people whose primary reason for vaping is anxiety management, starting NRT before the quit date, so the baseline is already established when the device is removed, is a practical strategy that reduces the anxiety spike during the first week.
The sleep connection
Anxiety and sleep are linked in both directions, and nicotine disrupts both. Nicotine suppresses deep slow-wave sleep and causes micro-awakenings as blood levels drop overnight. Poor sleep raises cortisol, lowers frustration tolerance, and amplifies anxiety the following day. The vaper who reaches for the device to manage anxiety is often dealing with anxiety that was partly caused by the sleep disruption the device produced the night before.
This creates a second feedback loop running in parallel with the withdrawal cycle. The withdrawal loop operates within hours: nicotine wears off, anxiety rises, the next hit provides relief. The sleep loop operates across days: nicotine disrupts sleep, poor sleep elevates anxiety the next day, the elevated anxiety increases vaping frequency, and more nicotine disrupts sleep further. Both loops are operating simultaneously, and both resolve after quitting, but the sleep loop takes longer. Most former vapers report meaningful sleep improvement within three to four weeks, and the anxiety that was partly sleep-driven improves on a similar timeline.
This is worth knowing because it means the full anxiety improvement from quitting may not be apparent in the first week. The withdrawal anxiety peaks and falls on a known schedule, but the sleep-related anxiety component improves more gradually as sleep architecture recovers. The people who report that their anxiety at three months post-quit is lower than at any point during their vaping are likely seeing the combined resolution of both loops.
A note for people with diagnosed anxiety
If you have a diagnosed anxiety disorder (GAD, social anxiety, panic disorder), quitting nicotine may temporarily intensify your symptoms. This does not mean you should not quit; it means the quit attempt benefits from coordination with a clinician who can monitor your symptoms and adjust any existing treatment during the transition. NRT is particularly important in this group, because it smooths the nicotine withdrawal and reduces the anxiety spike that would otherwise compound the underlying condition.
For this group, the distinction between withdrawal-driven anxiety and disorder-driven anxiety is harder to make in real time. Both feel the same. The practical approach is to treat them as overlapping: manage the withdrawal pharmacologically with NRT, manage the disorder with the existing treatment plan, and expect that the two will be difficult to disentangle for the first few weeks. After the withdrawal resolves, the underlying anxiety level becomes clearer, and many people in this group find it is lower than they expected.
If you’d like support quitting, the Quitline (1-800-QUIT-NOW in the US) and smokefree.gov have free resources. Your doctor or pharmacist can also advise on NRT.
Frequently asked questions
Does vaping help with anxiety?
Vaping relieves nicotine withdrawal symptoms, which include anxiety-like feelings. This creates the perception that vaping reduces anxiety. But the withdrawal it is relieving was caused by the nicotine itself. Longitudinal studies associate regular vaping with increased anxiety over time.
Does nicotine make anxiety worse?
Regular nicotine use is associated with higher anxiety levels in population studies. The acute relief from each hit reflects withdrawal management, not anxiety treatment. Quitting nicotine is associated with reduced anxiety after the withdrawal period.
Will my anxiety get worse when I quit vaping?
Yes, temporarily. Nicotine withdrawal includes increased anxiety and irritability, typically peaking in the first week. Most people report that their baseline anxiety improves within a month of quitting, often to levels lower than while vaping.
Should I treat my anxiety before quitting vaping?
If you have a diagnosed anxiety disorder, talking to a doctor about managing it during a quit attempt is a good idea. But for most vapers, the apparent anxiety is substantially driven by nicotine dependence itself, and quitting addresses it.
Sources and further reading
- Taylor GMJ et al. — Change in mental health after smoking cessation: systematic review and meta-analysis
BMJ, 2021, meta-analysis of 102 studies, n over 169,000. Quitting smoking associated with reduced anxiety, depression and stress. DOI: 10.1136/bmj.n782
- Leventhal AM et al. — Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence
JAMA, 2015, longitudinal cohort of 2,530 adolescents. Context for e-cigarette use patterns. DOI: 10.1001/jama.2015.8950
- Obisesan OH et al. — Association between e-cigarette use and depression in the behavioral risk factor surveillance system
JAMA Network Open, 2020, cross-sectional analysis of 886,731 adults. E-cigarette use associated with depression and anxiety. DOI: 10.1001/jamanetworkopen.2020.12562
- Hughes JR — Effects of abstinence from tobacco: valid symptoms and time course
Nicotine & Tobacco Research, 2007, meta-analysis of withdrawal symptom time course including anxiety. DOI: 10.1080/14622200600789600
- Kutlu MG et al. — Nicotine modulation of fear memories and anxiety
Current Psychiatry Reports, 2015, review of nicotine-anxiety interactions in preclinical and clinical studies. DOI: 10.1007/s11920-015-0604-3
Sources checked May 28, 2025. This is an editorial summary, not a systematic review or individual advice.